These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11258883)

  • 21. Towards a complete description of the structural and dynamic properties of the denatured state of barnase and the role of residual structure in folding.
    Wong KB; Clarke J; Bond CJ; Neira JL; Freund SM; Fersht AR; Daggett V
    J Mol Biol; 2000 Mar; 296(5):1257-82. PubMed ID: 10698632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational analysis of thermal stability: effect of Ile-->Val mutations in human lysozyme.
    Sugita Y; Kitao A; Go N
    Fold Des; 1998; 3(3):173-81. PubMed ID: 9562548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing nature of the protein folding transition state: implications for the shape of the free-energy profile for folding.
    Oliveberg M; Tan YJ; Silow M; Fersht AR
    J Mol Biol; 1998 Apr; 277(4):933-43. PubMed ID: 9545382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folding of chymotrypsin inhibitor 2. 1. Evidence for a two-state transition.
    Jackson SE; Fersht AR
    Biochemistry; 1991 Oct; 30(43):10428-35. PubMed ID: 1931967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative activation enthalpies in the kinetics of protein folding.
    Oliveberg M; Tan YJ; Fersht AR
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8926-9. PubMed ID: 7568045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Energy Channeling and Malleable Transition States: Molecular Dynamics Simulations and Free Energy Landscapes for the Thermal Unfolding of Protein U1A and 13 Mutants.
    Dang NL; Baranger AM; Beveridge DL
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folding of a pressure-denatured model protein.
    Mohana-Borges R; Silva JL; Ruiz-Sanz J; de Prat-Gay G
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7888-93. PubMed ID: 10393917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Movement of the position of the transition state in protein folding.
    Matouschek A; Otzen DE; Itzhaki LS; Jackson SE; Fersht AR
    Biochemistry; 1995 Oct; 34(41):13656-62. PubMed ID: 7577956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of the folding/unfolding transition state ensemble of chymotrypsin inhibitor 2 to changes in temperature and solvent.
    Day R; Daggett V
    Protein Sci; 2005 May; 14(5):1242-52. PubMed ID: 15840831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Search for nucleation sites in smaller fragments of chymotrypsin inhibitor 2.
    Itzhaki LS; Neira JL; Ruiz-Sanz J; de Prat Gay G; Fersht AR
    J Mol Biol; 1995 Nov; 254(2):289-304. PubMed ID: 7490749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutamine, alanine or glycine repeats inserted into the loop of a protein have minimal effects on stability and folding rates.
    Ladurner AG; Fersht AR
    J Mol Biol; 1997 Oct; 273(1):330-7. PubMed ID: 9367765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The folding pathway of ubiquitin from all-atom molecular dynamics simulations.
    Marianayagam NJ; Jackson SE
    Biophys Chem; 2004 Oct; 111(2):159-71. PubMed ID: 15381313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular dynamics study of the stability of staphylococcal nuclease mutants: component analysis of the free energy difference of denaturation.
    Yamaotsu N; Moriguchi I; Kollman PA; Hirono S
    Biochim Biophys Acta; 1993 Apr; 1163(1):81-8. PubMed ID: 8476933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Context dependence of protein secondary structure formation: the three-dimensional structure and stability of a hybrid between chymotrypsin inhibitor 2 and helix E from subtilisin Carlsberg.
    Osmark P; Sørensen P; Poulsen FM
    Biochemistry; 1993 Oct; 32(41):11007-14. PubMed ID: 8218165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conserved residues and the mechanism of protein folding.
    Shakhnovich E; Abkevich V; Ptitsyn O
    Nature; 1996 Jan; 379(6560):96-8. PubMed ID: 8538750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Side-chain determinants of beta-sheet stability.
    Otzen DE; Fersht AR
    Biochemistry; 1995 May; 34(17):5718-24. PubMed ID: 7727432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of hydrophilic to hydrophobic surface mutations on the denatured state of iso-1-cytochrome c: investigation of aliphatic residues.
    Herrmann L; Bowler BE; Dong A; Caughey WS
    Biochemistry; 1995 Mar; 34(9):3040-7. PubMed ID: 7893716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folding of chymotrypsin inhibitor 2. 2. Influence of proline isomerization on the folding kinetics and thermodynamic characterization of the transition state of folding.
    Jackson SE; Fersht AR
    Biochemistry; 1991 Oct; 30(43):10436-43. PubMed ID: 1931968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
    Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
    Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of protein-unfolding transition states identified in molecular dynamics simulations.
    Daggett V
    Biochem Soc Symp; 2001; (68):83-93. PubMed ID: 11573349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.